
Medicinal cannabis in Australia existed in a regulatory grey zone. Misinformation was everywhere, stigma was the default, and patients had nowhere credible to turn. honahlee needed to be the trusted source before it could be a commercial platform. Education had to lead.
The Australian medicinal cannabis market was nascent but growing rapidly. Patient access schemes were expanding and public sentiment was shifting. honahlee needed a platform architecture that could scale with the regulatory landscape while holding editorial credibility.
We designed a platform for education first, commerce second. Credible content and a clear information architecture came before any commercial layer, so trust was built before anything was sold.


Antimony delivered audience journey mapping, business and ideation workshops, content design, custom illustration, website design, full custom development, and training and support. Every decision made to build a platform that felt authoritative yet accessible.
The platform launched with 20+ expert contributors and health professionals, strain databases and educational resources. Antimony designed the information architecture to guide users from curiosity to informed decision-making across a complex and sensitive topic.
Within 12 months, honahlee grew to 6,500+ community members and 102,000 website visitors, with 3x platform growth year-on-year. It expanded to launch Catalyst, an alternative medicines and script database, driving 200% revenue growth and proving the model could scale into adjacent health verticals.
